Evolution of an Epidemic: Taming a Killer Virus

AIDS—acquired immunity deficiency syndrome—was named in 1982, at the beginning of the epidemic in the U.S. It was another two years before it was known that human immunodeficiency virus (HIV) was the cause of this strange new disease. Death rates rose steadily and steeply over the next decade. By the mid-1990s, AIDS was the leading cause of death for Americans ages 25 to 44 and more than 250,000 people had died from AIDS or AIDS-related causes. “Some of our most creative people were taken away from us by this terrible disease,” says Emory synthetic chemist Dennis Liotta. “I became increasingly Read More …

Marianne Swanson: The Survivor

Marianne Swanson, a senior staff nurse at Grady Health System’s Ponce Center, was born and raised in Brooklyn, in a close-knit Italian-American family and community. She lost her first husband and two of her three children to AIDS, and she is HIV positive. This is her story: Starting a family: Jeff and I were in a singing group in a Catholic Church, that was where we met. We fell in love and got married in a small Christian church in Brooklyn. We were married for about two years before I got pregnant with our first son, Jonathan. My second son Read More …

Nina Martinez: The HIV Positive Twin

Public health analyst Nina Martinez is 35 years old and has been living with HIV for all but six weeks of her life. Her father was active duty Navy, and she’s a twin. She has HIV while her twin does not. This is her story: How it happened: My twin and I were born 12 weeks early and at that time in the mid-1980s you needed to take a lot of lab work. Because they took labs so often, we were both anemic. We required blood transfusions at 6 weeks old. I was transported to San Francisco and she remained Read More …

Dennis Liotta: The Chemist

Synthetic chemist Dennis Liotta, PhD, Samuel Candler Dobbs Professor at Emory and executive director of the Emory Institute for Drug Development, is the co-developer of an antiretroviral drug that has saved the lives of countless people living with HIV around the world. Starting out: Liotta says he was “genetically coded to be a chemist.” Not only was he naturally drawn to the field, he was able to follow the footsteps of his oldest brother, an organic chemist at Georgia Tech. “Charles was my first scientific role model,” Liotta says. “He is one of the most gifted teachers I’ve ever seen. Read More …

Raymond Schinazi: The Virologist

Organic medicinal chemist and virologist Raymond Schinazi, PhD, the Frances Winship Walters Professor of Pediatrics at Emory and director of the Laboratory of Biochemical Pharmacology, was born in Egypt to Italian parents. In 1962 his family was threatened by the Nasser regime and immigrated to Naples as refugees. He went to boarding school in the UK, where he was a chemistry major at Bath University, and later came to the U.S. and studied pharmacology at Yale University before beginning his career at Emory. The path to chemist: I was actually pretty good at chemistry. I wanted to by a physicist, but Read More …

George Painter: The Corporate Partner

George Painter, PhD, is the chief executive officer of DRIVE, a not-for-profit company wholly owned by Emory University but with the independence to run like a biotechnology company. He recalls his career and its intersection with the innovations in Dennis Liotta’s lab, where critical HIV antiretroviral drugs were created. Meeting Dennis Liotta: Dennis came to Emory in 1976. I was a senior graduate student, and he was a young assistant professor, so he was here (at Emory) all hours of the day and night as was I, so we became acquainted. But really, the reason I kept coming and going from Read More …

Jeff Lennox: The HIV Physician

Jeff Lennox, MD, is an Emory professor of medicine, Emory chief of internal medicine at Grady Memorial Hospital and the former medical director of the infectious disease program at the Ponce de Leon Center. “At Grady, we see patients from every continent except Antarctica, so we take care of patients with a wide variety of infectious diseases,” he says.” In addition, Grady has one of the largest populations of HIV-infected patients in the United States.” Here, Lennox tells how he came to specialize in infectious disease and HIV.  A new disease: As a medical student, I was fascinated with bacteria Read More …